Cell & Gene Therapy Innovation Speaker
André G. Gerth
Chief Executive Officer
Following his PhD in 1991, he worked as a managing partner in several biotechnology companies in Germany. Today he acts as Chief executive Officer Director of BioPlanta GmbH and FamiCord Deutschland GmbH. From 2012 to 2017 Dr. André Gerth was appointed as Chairman of the Management Board of Vita 34 AG, one of the largest stem cell banks in Europe. Currently André Gerth is responsible in the Management Board for Strategy, Production, Research and Development. André is focussed on the development and manufacturing of stem cell products and Clinical Trials of stem cell pharmaceuticals and tissue engineered products.